Skip to content

Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02767622
Enrollment
40
Registered
2016-05-10
Start date
2014-06-30
Completion date
Unknown
Last updated
2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimal Hepatic Encephalopathy

Brief summary

This study included 20 patients listed for liver transplantation in addition to 20 age- and sex- matched controls. Neurological, psychiatric, laboratory and radiological examinations were performed for both patients and controls before and 6 months after liver transplantation. Assessment of cognitive functions by Trail Making Test A (TMT A), TMT B, Digit Symbol Test (DST), and Serial Dotting Test (SDT) was done before and after liver transplantation.

Interventions

PROCEDURELiver transplantation

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Right handed patients with biopsy-proven liver cirrhosis listed for liver transplantation

Exclusion criteria

* Overt hepatic encephalopathy. * Significant cortical atrophy or other structural brain changes revealed by conventional neuro-imaging. * Regular use of psychotropic drugs, such as benzodiazepines. * Known major psychiatric disorder. * Less than 6 months of complete alcohol abstinence. * Post-transplant toxic levels of immunosuppressive drugs. * Patients unable to perform the tests (Illiterate or upper limb motor handicaps).

Design outcomes

Primary

MeasureTime frame
Improvement of Psychometric tests.6 months following liver transplantation.

Secondary

MeasureTime frame
Improvement of liver functions and MELD score following liver transplantation.6 months following liver transplantation.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026